Banner

Cole National amends deal with Luxottica

Article

The board of directors of Cole National Corp. unanimously approved an amendment to its merger agreement with Luxottica Group SpA.

Related Videos
Related Content

Managing a sticky situation: Real World Ophthalmology

September 24th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Eyecbetter announces Amy Dixon, PLY (Paralympian), as new Director of Patient Advocacy

September 23rd 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

Enhancing surgical outcomes through effective dry eye disease management

September 22nd 2023

Managing a sticky situation: Real World Ophthalmology

September 24th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Eyecbetter announces Amy Dixon, PLY (Paralympian), as new Director of Patient Advocacy

September 23rd 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

Enhancing surgical outcomes through effective dry eye disease management

September 22nd 2023

Managing a sticky situation: Real World Ophthalmology

September 24th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Eyecbetter announces Amy Dixon, PLY (Paralympian), as new Director of Patient Advocacy

September 23rd 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

Enhancing surgical outcomes through effective dry eye disease management

September 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.